Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1)

Douglas S. Williamson, Garrick P. Smith, Pamela Acheson-Dossang, Simon T. Bedford, Victoria Chell, I-Jen Chen, Justus C. A. Daechsel, Zoe Daniels, Laurent David, Pawel Dokurno, Morten Hentzer, Martin C. Herzig, Roderick E. Hubbard, Jonathan D. Moore, James B. Murray, Samantha Newland, Stuart C. Ray, Terry Shaw, Allan E. Surgenor, Lindsey TerryKenneth Thirstrup, Yikang Wang, Kenneth V. Christensen

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)8945-8962
Number of pages18
Issue number21
Publication statusPublished - 12 Oct 2017

Bibliographical note

© 2017 American Chemical Society. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details

Cite this